-
10009986-1An analog of curcumin obtained by methylation of both free phenolic groups in the parent compound 30-fold increase in potency was observed in the growth suppression of HCT116 tumor cells following this modification.
-
10009986-10An analog of curcumin obtained by methylation of both free phenolic groups in the parent compound 30-fold increase in potency was observed in the growth suppression of HCT116 tumor cells following this modification.
-
10009986-5An analog of curcumin obtained by methylation of both free phenolic groups in the parent compound 30-fold increase in potency was observed in the growth suppression of HCT116 tumor cells following this modification.
-
17869-10A planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis 250 µg/ml stimulates JAK/STAT signaling and induces the expression of interferon-&alpha stimulated genes in a HepG2 cell line.
-
17869-100A planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis 250 µg/ml stimulates JAK/STAT signaling and induces the expression of interferon-&alpha stimulated genes in a HepG2 cell line.
-
17869-25A planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis 250 µg/ml stimulates JAK/STAT signaling and induces the expression of interferon-&alpha stimulated genes in a HepG2 cell line.
-
17869-50A planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis 250 µg/ml stimulates JAK/STAT signaling and induces the expression of interferon-&alpha stimulated genes in a HepG2 cell line.
-
18602-10A cell-permeant glutamic acid derivative that enhances insulin release in response to glucose in isolated islets and in animal models of diabetes also potentiates the insulinotropic potential of glyburide and GLP-1.
-
18602-25A cell-permeant glutamic acid derivative that enhances insulin release in response to glucose in isolated islets and in animal models of diabetes also potentiates the insulinotropic potential of glyburide and GLP-1.
-
18602-5A cell-permeant glutamic acid derivative that enhances insulin release in response to glucose in isolated islets and in animal models of diabetes also potentiates the insulinotropic potential of glyburide and GLP-1.
-
18602-50A cell-permeant glutamic acid derivative that enhances insulin release in response to glucose in isolated islets and in animal models of diabetes also potentiates the insulinotropic potential of glyburide and GLP-1.
-
14714-100A lipophilic electrophile that has profound effects on oxidative and immunological pathways activates the transcription factor Nrf2, resulting in heme oxygenase-1 expression and increased glutathione levels suppresses the expression of